PUF RNA-Binding Polypeptides for Specific Cytosine Recognition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current RNA interference (RNAi) technologies face challenges such as complex design requirements, limited specificity, cross-hybridization, non-specific binding, and immune activation, making them inefficient for precise gene regulation.
Innovation Solution
Development of recombinant polypeptides with PUF RNA-binding domains capable of specifically binding to cytosine RNA bases, allowing for targeted gene regulation through modular and synergistic binding motifs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If RNAi technology is used for gene regulation, then gene expression can be suppressed, but design complexity and specificity issues arise
Solution Approach 1:
The patent changes the fundamental parameter of RNA binding from sequence-specific Watson-Crick base pairing (RNAi) to structure-specific binding (PUF proteins). The PUF proteins bind to the minor groove of RNA helices, recognizing structural features rather than specific nucleotide sequences, thereby achieving high specificity without complex design requirements.
Solution Approach 2:
The patent extracts the RNA binding function from the complex RNAi machinery and isolates it into a simplified protein-based system. By using PUF proteins that directly bind RNA without requiring RISC complex assembly, strand selection, or cellular processing, the system eliminates the complexity of RNAi while maintaining gene regulation capability.
2Reliability
If siRNA is used for gene silencing, then translation and mRNA degradation occur, but cross-hybridization and non-specific binding happen
Solution Approach 1:
The patent applies local quality by having different PUF proteins bind to different local structural regions of RNA. Each PUF protein is designed to recognize a specific local structural motif within the RNA helix, allowing selective binding to particular genes without affecting other RNAs with different sequences but similar overall structure.
Solution Approach 2:
The patent introduces RNA structure as an intermediary between the protein and the gene target. Instead of direct sequence-specific pairing (which causes cross-hybridization), the PUF proteins bind to the structural intermediary of the RNA helix, providing a buffer that prevents non-specific interactions while maintaining specific gene targeting.
3Reliability
If siRNA-mediated binding is used, then target mRNA cleavage occurs, but immune activation and inflammatory response are triggered
Solution Approach 1:
The patent converts the potential harm of immune activation into a benefit by using PUF proteins that naturally bind RNA without triggering immune responses. The PUF proteins utilize the minor groove binding mechanism, which is biologically benign and does not activate pattern recognition receptors, thereby eliminating the harmful immune response while maintaining effective gene silencing.
4Reliability
If canonical Watson and Crick base pairing is used for RNA-RNA interaction, then specific binding occurs, but binding affinity is limited
Solution Approach 1:
The patent inverts the conventional approach by having proteins bind to RNA structure rather than RNA binding to protein through base pairing. The PUF proteins bind to the minor groove of RNA helices, inverting the traditional direction of interaction and enabling stronger, more specific binding through protein-RNA contacts that are not constrained by Watson-Crick pairing rules.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The recombinant polypeptides provide enhanced specificity and efficiency in regulating gene expression by binding to cytosine RNA bases, reducing non-specific interactions and immune activation, thus offering a more precise control over gene expression.
Implementation Method 1
recombinant polypeptides with PUF RNA-binding domains capable of specifically binding to cytosine RNA bases
Data Source
AI summary
A recombinant polypeptide is described which comprises at least one PUF RNA-binding domain capable of specifically binding to a cytosine RNA base. The PUF RNA-binding domain of the polypeptide comprises at least one RNA base-binding motif of the general formula X1X2X3X4X5X6X7X8X9X10X11 wherein X1 is selected from the group including glutamine (Q), valine (V), methionine (M), proline (P), glutamic acid (E), and lysine (K); X2 is selected from the group including histidine (H), phenylalanine (F), tyrosine (Y), and asparagine (N); X3 is selected from the group including glycine (G) and alanine (A); X4 is selected from the group including glycine (G), alanine (A), serine (S), threonine (T) and cysteine (C); X5 is selected from the group including arginine (R), tyrosine (Y), histidine (H), and asparagine (N); X6 is selected from the group including phenylalanine (F), leucine (L), and valine (V); X7 is selected from the group including isoleucine (I), leucine (L), and valine (V); X8 is arginine (R); X9 is selected from the group including leucine (L), lysine (K), arginine (R), glutamine (Q), and histidine (H); X10 is selected from the group including lysine (K), phenylalanine (F), alanine (A), cysteine (C), isoleucine (I), valine (V), leucine (L), and methionine (M); and X11 is selected from the group including leucine (L), phenylalanine (F), isoleucine (I), and valine (V); and wherein the RNA base-binding motif is operably capable of specifically binding to a cytosine RNA base.